Literature DB >> 6423352

Diabetic ketoacidosis during long-term treatment with continuous subcutaneous insulin infusion.

N R Peden, J T Braaten, J B McKendry.   

Abstract

During 1880 patient-months of treatment with continuous subcutaneous insulin infusion in 101 patients with IDDM, 36 episodes of acute, severe loss of glycemic control, including 29 with significant ketoacidosis, occurred in 20 patients. Fifteen episodes were attributable to failure of insulin delivery to the patient while 13 were precipitated by infection. Insufficiently frequent blood glucose monitoring, failure by patients to detect mechanical and technical problems with infusion systems, failure to adhere to "sick day" regimens, and delay in seeking medical help all contributed to the progression of a number of episodes. Thirst, nausea, and vomiting were the common clinical manifestations of decompensation; and the degree of acidemia was often mild in relation to the degree of hyperglycemia. Response to conventional management was usually prompt.

Entities:  

Mesh:

Year:  1984        PMID: 6423352     DOI: 10.2337/diacare.7.1.1

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  13 in total

1.  Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.

Authors:  A J Scheen; J Gillet; J Rosenthaler; J Guiot; P Henrivaux; B Jandrain; P J Lefèbvre
Journal:  Diabetologia       Date:  1989-11       Impact factor: 10.122

Review 2.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Effect of improved metabolic control on loss of kidney function in type 1 (insulin-dependent) diabetic patients: an update of the Steno studies.

Authors:  B Feldt-Rasmussen; E R Mathiesen; T Jensen; T Lauritzen; T Deckert
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

4.  Insulin pump failures are still frequent: a prospective study over 6 years from 2001 to 2007.

Authors:  I Guilhem; B Balkau; F Lecordier; J-M Malécot; S Elbadii; A-M Leguerrier; J-Y Poirier; C Derrien; F Bonnet
Journal:  Diabetologia       Date:  2009-10-16       Impact factor: 10.122

5.  Diabetic ketoacidosis: current views on pathogenesis and treatment.

Authors:  U Keller
Journal:  Diabetologia       Date:  1986-02       Impact factor: 10.122

6.  Predicting risk of diabetic ketoacidosis in patients using continuous subcutaneous insulin infusion.

Authors:  C Bradley; D S Gamsu; G Knight; A J Boulton; J D Ward
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

7.  Intrauterine death during continuous subcutaneous infusion of insulin.

Authors:  J M Steel; C P West
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

8.  Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience.

Authors:  E Chantelau; M Spraul; I Mühlhauser; R Gause; M Berger
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

Review 9.  Hyperglycemic crises in adult patients with diabetes.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; John M Miles; Joseph N Fisher
Journal:  Diabetes Care       Date:  2009-07       Impact factor: 17.152

Review 10.  Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion.

Authors:  Lutz Heinemann; Lars Krinelke
Journal:  J Diabetes Sci Technol       Date:  2012-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.